Johnson & Johnson said Monday it planned to terminate its Covid-19 vaccine supply deal with contract manufacturer Emergent BioSolutions Inc., as both companies accused each other of breaching the agreement.
J&J informed Emergent last week of its plan to terminate the 2020 manufacturing agreement “based on Emergent’s breaches, including failure to supply Covid-19 vaccine drug substance,” J&J said in a written statement.
